New approaches to the assessment of vaccine herd protection in clinical trials
Authors:
- John ClemensJCJohn Clemens
- Sunheang ShinSSSunheang Shin
- Mohammad AliMAMohammad Ali
- 1 June 2011
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 11 (6) , 482-487
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cost-Effectiveness of New-Generation Oral Cholera Vaccines: A Multisite AnalysisValue in Health, 2009
- A Cluster-Randomized Effectiveness Trial of Vi Typhoid Vaccine in IndiaNew England Journal of Medicine, 2009
- Controlling Endemic Cholera with Oral VaccinesPLOS Medicine, 2007
- Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United KingdomEpidemiology and Infection, 2007
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- Reassessing the Cost-Effectiveness of Meningococcal Serogroup C Conjugate (MCC) Vaccines Using a Transmission Dynamic ModelMedical Decision Making, 2006
- The Japanese Experience with Vaccinating Schoolchildren against InfluenzaNew England Journal of Medicine, 2001
- Reduction of Nasopharyngeal Carriage of Pneumococci during the Second Year of Life by a Heptavalent Conjugate Pneumococcal VaccineThe Journal of Infectious Diseases, 1996
- Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian childrenThe Pediatric Infectious Disease Journal, 1993
- Vaccination and herd immunity to infectious diseasesNature, 1985